ArticleJournal of virology2026
Genetic background modifies host and viral parameters of neonatal gammaherpesvirus infection.
Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Gammaherpesviruses are ubiquitous pathogens that establish lifelong infection and are associated with cancer and multiple sclerosis. Primary infection during adolescence significantly increases the risk of gammaherpesvirus-driven disease in humans. Correspondingly, infection of adolescent mice with murine gammaherpesvirus 68 (MHV68) has served as a tractable animal model to define host factors that control chronic gammaherpesvirus infection and pathogenesis. However, a majority of humans are infected with gammaherpesviruses during early life when the nature of adaptive immune responses is altered as compared to that of older children and adults. Given that human and murine gammaherpesviruses manipulate B cell differentiation to establish the latent reservoir in adolescents, this study aims to define the host and viral parameters of chronic gammaherpesvirus infection following neonatal inoculation. Similar to adolescents, MHV68-driven germinal center responses and the establishment of a latent viral reservoir in splenic germinal center B cells of BALB/c mice were reliably observed following neonatal intranasal infection with 400 PFU of MHV68. Unexpectedly, MHV68-driven splenomegaly, a ubiquitous clinical manifestation of gammaherpesvirus infection in recently infected adolescent mice and humans, was only observed in neonatally infected BALB/c males and not females. Interestingly, C57BL/6J neonates were largely resistant to the establishment of latent splenic infection following 400 PFU intranasal inoculation. Increasing the MHV68 inoculum rescued the establishment of chronic splenic infection and MHV68-driven germinal center responses in neonatally infected C57BL/6J mice. Thus, the current study unveils the role of genetic background and early life exposure in the susceptibility to systemic gammaherpesvirus infection.IMPORTANCEPrimary gammaherpesvirus infection of adolescents is associated with increased risk of gammaherpesvirus-driven disease, such as cancer and multiple sclerosis. Therefore, the murine gammaherpesvirus 68 (MHV68) animal model has served as a tractable experimental system to define host factors involved in control of gammaherpesvirus infection and pathogenesis following adolescent infection. However, a majority of human gammaherpesvirus infections occur during early childhood, a stage of human development that is marked by unique differences in the adaptive immune responses as compared to that of adults. This study demonstrates that the genetic background plays an important role in limiting systemic gammaherpesvirus infection following neonatal viral exposure, in contrast to that historically observed in primary adolescent infection. However, when susceptible to systemic infection, the extent of MHV68-driven germinal center responses and establishment of a latent viral reservoir in germinal center B cells are largely comparable between neonatally infected mice and published observations in adolescent MHV68 infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.